Access to the KKR Investor Portal is provided to investors in Drawbridge Realty Partners, L.P. (the “Drawbridge Fund”) by Kohlberg Kravis Roberts & Co. L.P. (together with its affiliates, “KKR”) solely in KKR’s capacity as an administrator to the Drawbridge Fund and at the direction of Drawbridge Realty (“Drawbridge”). Information regarding the Drawbridge Fund accessed through the KKR Investor Portal is confidential and intended for Drawbridge Fund investors only. The recipient should not distribute this Communication to any person (other than its legal, investment or tax advisors) without the prior consent of Drawbridge.
Drawbridge is an independently managed real estate investment vehicle. KKR has a financial and/or control interest in, and provides certain services to the Drawbridge Fund and/or its sponsor, but KKR is not the investment advisor to the Drawbridge Fund or any portfolio investment of the Drawbridge Fund. Further, KKR is under no obligation to provide the Drawbridge Fund with investment opportunities and in many cases will be prohibited from doing so by KKR’s internal policies and procedures. No person should rely upon the past performance or reputation of KKR or its investment products when considering any security offered by the Drawbridge Fund or Drawbridge.
何 思寧（拠点：東京）2018年11月にKKR入社。KKRではPHCホールディングス（旧パナソニックヘルスケア）及び同社追加買収先であるEpredia（サーモフィッシャーサイエンティフィック社からカーブアウト）、LSIメディエンス（三菱ケミカルホールディングスからカーブアウト）、弥生、武州製薬への投資に関与。現在弥生において社外監査役を務める。KKR入社以前は、JPモルガン証券投資銀行部門にて、金融法人グループにおけるクロスボーダーM&A案件や資金調達案件に関与。東京大学経済学部にて学士号取得。